PetIQ, Inc. (PETQ)

NASDAQ: PETQ · IEX Real-Time Price · USD
+0.18 (1.43%)
At close: May 31, 2023, 4:00 PM
+0.17 (1.34%)
After-hours: May 31, 2023, 5:48 PM EDT

Company Description

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally.

It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications.

It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars.

In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products.

The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands.

In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks.

It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels.

The company was founded in 2010 and is headquartered in Eagle, Idaho.

PetIQ, Inc.
PetIQ logo
Country United States
Founded 2010
IPO Date Jul 21, 2017
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,076
CEO McCord Christensen

Contact Details

Petiq Llc, 230 E. Riverside Dr.
Eagle, Idaho 83616
United States
Phone 208-939-8900

Stock Details

Ticker Symbol PETQ
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001668673
CUSIP Number 71639T106
ISIN Number US71639T1060
SIC Code 5122

Key Executives

Name Position
McCord Christensen Chairman and Chief Executive Officer
Michael A. Smith President and Chief Operating Officer
Robert Michael Herrman Executive Vice President, General Counsel and Corporate Secretary
Zvi Glasman Chief Financial Officer
John Pearson Senior Vice President and Head of Services Division

Latest SEC Filings

Date Type Title
May 31, 2023 8-K Current Report
May 10, 2023 10-Q Quarterly Report
May 9, 2023 8-K Current Report
Apr 28, 2023 ARS Filing
Apr 28, 2023 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 28, 2023 DEF 14A Other definitive proxy statements
Mar 1, 2023 10-K Annual Report
Feb 28, 2023 8-K Current Report
Feb 14, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals